BioHarvest Sciences Inc.
CNVCF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $74,974 | $99,730 | $156,841 | $61,196 |
| - Cash | $5,355 | $1,736 | $4,117 | $1,783 |
| + Debt | $22,341 | $10,558 | $2,273 | $2,715 |
| Enterprise Value | $91,960 | $108,552 | $154,997 | $62,128 |
| Revenue | $12,672 | $5,498 | $2,102 | $396 |
| % Growth | 130.5% | 161.6% | 430.8% | – |
| Gross Profit | $5,633 | $1,219 | $670 | $138 |
| % Margin | 44.5% | 22.2% | 31.9% | 34.8% |
| EBITDA | -$9,763 | -$9,125 | -$8,633 | -$5,774 |
| % Margin | -77% | -166% | -410.7% | -1,458.1% |
| Net Income | -$12,564 | -$11,236 | -$9,827 | -$6,584 |
| % Margin | -99.1% | -204.4% | -467.5% | -1,662.6% |
| EPS Diluted | -0.93 | -0.86 | -0.79 | -0.68 |
| % Growth | -8.1% | -8.9% | -16.2% | – |
| Operating Cash Flow | -$8,522 | -$9,241 | -$6,794 | -$3,875 |
| Capital Expenditures | -$1,474 | -$1,256 | -$1,640 | -$173 |
| Free Cash Flow | -$9,996 | -$10,497 | -$8,434 | -$4,048 |